Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in […]
VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) — Imperial Metals Corporation (“Imperial”) (TSX:III) reports that 2023 metal production from […]